Correlation Between Iovance Biotherapeutics and Dynavax Technologies
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Dynavax Technologies, you can compare the effects of market volatilities on Iovance Biotherapeutics and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Dynavax Technologies.
Diversification Opportunities for Iovance Biotherapeutics and Dynavax Technologies
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Iovance and Dynavax is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Dynavax Technologies go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Dynavax Technologies
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Dynavax Technologies. In addition to that, Iovance Biotherapeutics is 3.31 times more volatile than Dynavax Technologies. It trades about -0.3 of its total potential returns per unit of risk. Dynavax Technologies is currently generating about 0.11 per unit of volatility. If you would invest 1,289 in Dynavax Technologies on December 4, 2024 and sell it today you would earn a total of 105.50 from holding Dynavax Technologies or generate 8.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Dynavax Technologies
Performance |
Timeline |
Iovance Biotherapeutics |
Dynavax Technologies |
Iovance Biotherapeutics and Dynavax Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Dynavax Technologies
The main advantage of trading using opposite Iovance Biotherapeutics and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |